Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

LGALS8

Introduction

Lectin, galactoside-binding, soluble, 8 (galectin 8), also known as LGALS8, is a human gene.[1]

This gene encodes a member of the galectin family. Galectins are beta-galactoside-binding animal lectins with conserved carbohydrate recognition domains. The galectins have been implicated in many essential functions including development, differentiation, cell-cell adhesion, cell-matrix interaction, growth regulation, apoptosis, and RNA splicing. This gene is widely expressed in tumoral tissues and seems to be involved in integrin-like cell interactions. Alternatively spliced transcript variants encoding different isoforms have been identified.[1]

References

References

  1. ↑ 1.0 1.1 “Entrez Gene: LGALS8 lectin, galactoside-binding, soluble, 8 (galectin 8)”.
Further reading

Further reading

  • Bidon N, Brichory F, Bourguet P; et al. (2001). “Galectin-8: a complex sub-family of galectins (Review)”. Int. J. Mol. Med. 8 (3): 245–50. PMID 11494049.
  • Danguy A, Camby I, Kiss R (2002). “Galectins and cancer”. Biochim. Biophys. Acta. 1572 (2–3): 285–93. PMID 12223276.
  • Bidon-Wagner N, Le Pennec JP (2004). “Human galectin-8 isoforms and cancer”. Glycoconj. J. 19 (7–9): 557–63. doi:10.1023/B:GLYC.0000014086.38343.98. PMID 14758080.
  • Hadari YR, Paz K, Dekel R; et al. (1995). “Galectin-8. A new rat lectin, related to galectin-4”. J. Biol. Chem. 270 (7): 3447–53. PMID 7852431.
  • Su ZZ, Lin J, Shen R; et al. (1996). “Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family”. Proc. Natl. Acad. Sci. U.S.A. 93 (14): 7252–7. PMID 8692978.
  • Bassen R, Brichory F, Caulet-Maugendre S; et al. (2000). “Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissues”. Anticancer Res. 19 (6B): 5429–33. PMID 10697573.
  • Hadari YR, Arbel-Goren R, Levy Y; et al. (2000). “Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis”. J. Cell. Sci. 113 ( Pt 13): 2385–97. PMID 10852818.
  • Gopalkrishnan RV, Roberts T, Tuli S; et al. (2000). “Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene”. Oncogene. 19 (38): 4405–16. doi:10.1038/sj.onc.1203767. PMID 10980616.
  • Bidon N, Brichory F, Hanash S; et al. (2001). “Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line”. Gene. 274 (1–2): 253–62. PMID 11675018.
  • Nagy N, Bronckart Y, Camby I; et al. (2002). “Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor”. Gut. 50 (3): 392–401. PMID 11839721.
  • Maier C, Rösch K, Herkommer K; et al. (2003). “A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer”. Eur. Urol. 42 (3): 301–7. PMID 12234517.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Levy Y, Ronen D, Bershadsky AD, Zick Y (2003). “Sustained induction of ERK, protein kinase B, and p70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin”. J. Biol. Chem. 278 (16): 14533–42. doi:10.1074/jbc.M207380200. PMID 12569102.
  • Ideo H, Seko A, Ishizuka I, Yamashita K (2004). “The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity”. Glycobiology. 13 (10): 713–23. doi:10.1093/glycob/cwg094. PMID 12851289.
  • Nishi N, Shoji H, Seki M; et al. (2004). “Galectin-8 modulates neutrophil function via interaction with integrin alphaM”. Glycobiology. 13 (11): 755–63. doi:10.1093/glycob/cwg102. PMID 12881409.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Arbel-Goren R, Levy Y, Ronen D, Zick Y (2005). “Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8”. J. Biol. Chem. 280 (19): 19105–14. doi:10.1074/jbc.M502060200. PMID 15753078.

Template:WikiDoc Sources